Procter & Gamble Health Limited has informed the Exchange regarding a Press release on unaudited Financial Results for the quarter ended December 31, 2025.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has submitted to the NSE a press release containing its unaudited financial results for the third quarter of FY26, ending December 31, 2025. The filing itself is a regulatory disclosure and does not include the actual numbers in the headline; investors will need to refer to the attached press release for detailed revenue, profit, and segment-level figures. As a subsidiary of the global Procter & Gamble group, the company's quarterly performance is typically watched for trends in its vitamins, minerals, and supplements portfolio in India. The 'unaudited' tag indicates these are provisional numbers subject to a full audit later.
Neutral on its own — this is a standard quarterly results disclosure. The actual impact on the stock will depend on whether the underlying numbers (revenue growth, margins, profit) beat or miss market expectations once the detailed press release is reviewed.